A CIOMS Publication Series

Drug-induced Liver Injury (DILI)

Current status and future directions for drug development and the post-market setting.

Paperback
August 2020
9789290360995
More details
  • Publisher
    World Health Organization
  • Published
    6th August
  • ISBN 9789290360995
  • Language English
  • Pages 172 pp.
  • Size 6" x 9"
$22.00

This consensus report of the CIOMS DILI Working Group aims to provide a critical framework and essential set of tools to detect, diagnose, and manage DILI during drug development and in the post-marketing setting. The report is intended for clinical and basic pharmaceutical industry investigators who capture, analyze, and communicate liver safety data in drug development. It is also intended for regulatory scientists and expert consultants who comprehensively evaluate new products and emerging biomarkers for their association with DILI risk and for health care professionals who monitor and manage patients treated with potentially hepatotoxic drugs in clinical practice.

CIOMS DILI Working Group

No information

Drug-induced liver injury; DILI; drug development; clinical and basic pharmaceutical industry investigations; liver safety data; pharmaceutical regulation; hepatotoxic drugs